Services
- Aerospace Defense
- Business Interruption & Commercial Disputes
- Class Action Defense
- Complex Litigation
- Defense & Government Contracting
- Federal Claims
- Financial Institutions
- Government Investigations & White Collar Defense
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- Risk Mitigation & Management
Education
Washington and Lee University (B.A., 1977) St. John’s University, School of Law (J.D., 1980) U.S. Naval War College (M.A., 1985, National Security & Strategic Studies) Georgetown Law (LL.M., 1986, International & Comparative Law)Admissions
- District of Columbia
- New York
- Virginia
- United States Supreme Court
- United States Courts of Appeals for the Fourth, Sixth, Eleventh, District of Columbia, and Federal Circuits
- United States District Courts for the District of Columbia, District of Maryland, Eastern and Southern Districts of New York, Northern District of Texas, and Eastern District of Virginia
- United States Court of Appeals for the Armed Forces
- United States Court of Federal Claims
- United States Court of International Trade
Accolades
- “William Cople is a lead partner. It was an extremely complex case. He’s super thorough and on top of the details in a massive complex case. He really runs a complex litigation well. He’s a dogged cross-examiner too.”
–Client | Chambers USA - “William Cople is strategic and a very strong leader for the team.”
–Third Party | Chambers USA - 2023 Annual M&A Advisor Awards Winner “Professional Services Deal of the Year”, Deal Team Member
- Best Lawyers in America, Litigation-Construction, 2019-2025
- Super Lawyers, Government Contracts, 2014, 2017-2024
Memberships
- National Defense Industrial Association, Legal Committee
- ABA Litigation Section, Class Actions and Derivative Suits Committee, Pharmaceutical and Healthcare Subcommittee, Co-Chairman
- Defense Research Institute, Government Enforcement & Compliance Committee
- ABA Forum on Construction Law
- St. John’s Law Review, Editor
Insights & Events
It is an honor to be part of the ABA Military Pro Bono Project, which affords opportunities to help veterans confront many of the challenges they may face after returning to civilian life.
Congratulations to all of our Super Lawyers and Rising Stars
Amicus Curie Brief on Civil RICO Filed by Hollingsworth LLP Helps Catch Supreme Court’s Attention
news | November 28, 2023The civil Racketeer Influenced and Corrupt Organizations Act (“RICO”) statute, 18 U.S.C. § 1964(c), was originally enacted as a tool for fighting organized crime. The civil RICO statute allows recovery of treble damages for persons injured…
At the Annual M&A Advisor Awards, the firm – a member of the deal team for the 2022 acquisition of EYP Inc. by Page Southerland Page – was announced winner of the Professional Services Deal of the Year Award (deals of $50MM-$100MM).
The Firm congratulates fifteen attorneys named as 2023 Super Lawyers and Rising Stars for Washington, DC. The annual publication lists the top five percent of attorneys in each state, as chosen by their peers through a…
Hollingsworth LLP Major Defense Win in Ethylene Oxide Trial in Cook County, Illinois
news | November 18, 2022On November 18, 2022, a Cook County, Illinois jury returned a verdict in favor of Firm clients Sterigenics and Sotera Health, LLC after a twenty-eight day trial involving a plaintiff’s claims that emissions of ethylene oxide…
VerdictSearch Products Liability: “Bisphosphonate meds not cause of man’s ONJ”
news | August 21, 2014Four Firm partners credited for summary judgment decision in N.D. Ga. products liability case.
news | January 11, 2012DRI's The Voice
The U.S. District Court for the Northern District of Georgia issued a 69-page Daubert opinion in favor of our client in Rider/Siharath v. Sandoz Pharmaceuticals Corp., 131 F. Supp. 2d 1347 (N.D. Ga. 2001). Among the…
Cases
The Zometa Cases
- Precedent
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- Class Action Defense
- January 27, 2015
The core business model for products-liability plaintiffs’ lawyers depends increasingly on first amassing an inventory of claimants via consolidated state and federal proceedings, and then threatening big verdicts in early trials involving cherry-picked claims in favorable…
Hollingsworth LLP Secures Major Defense Verdict for Sterigenics and Sotera Health in Cook County, Ill. Trial
- Verdict
- Products Liability & Toxic Torts
- November 18, 2022
A Cook County, Illinois jury returned a verdict in favor of Firm clients Sterigenics and Sotera Health, LLC after a twenty-eight day trial involving a plaintiff’s claims that emissions of ethylene oxide from Sterigenics medical-device sterilization…
Novartis Successfully Defeats Punitive Damages Claim in Aredia/Zometa Litigation
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- July 10, 2014
The U.S. District Court for the Southern District of Ohio held that federal law preempted punitive damages under both Ohio and New Jersey law in Monroe v. Novartis Pharm. Corp. Plaintiffs in Monroe filed their complaint…
North Carolina Federal Jury Returns Defense Verdict in Favor of Novartis
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- May 14, 2014
Following a full day’s deliberations, a federal jury in Raleigh, North Carolina, returned a unanimous verdict in favor of Novartis Pharmaceuticals Corporation after a seven-day trial involving Aredia and Zometa, medicines used to prevent the devastating…
Novartis Rebuts Plaintiff’s Changing Failure-to-Warn Theories, Obtaining Summary Judgment on Eve of Trial
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- November 16, 2012
Judge Roger Titus of the U.S. District Court for the District of Maryland granted summary judgment in favor of Novartis Pharmaceuticals Corporation in a case alleging that plaintiff’s treatment with Novartis’s drugs Aredia and Zometa caused osteonecrosis…
In Major Precedent for Drugmakers, Federal Court Precludes Punitives Under New Jersey Law
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- September 5, 2012
Zimmerman v. Novartis Pharm. Corp., No. 8:08-cv-02089-RWT (D. Md. Sept, 5, 2012)
Western District of Oklahoma Grants Summary Judgment in for Novartis
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- July 18, 2012
Ingram v. Novartis Pharm. Corp., 888 F. Supp. 2d 1241 (W.D. Okla. 2012)
Judge William Duffey of the U.S. District Court for the Northern District of Georgia granted summary judgment in favor of Firm client Novartis Pharmaceuticals Corporation in a case alleging that plaintiff’s treatment with Novartis’s drugs Aredia…
Norwood v. Raytheon Co., 237 F.R.D. 581 (W.D. Tex. 2006)
- Case
- Products Liability & Toxic Torts
- September 11, 2006